Drug Availability Update
Further to DrugAlert Vol 631, HPS Pharmacies wish to give notice that Aspen Pharmacare Australia Pty Ltd is continuing to experience a supply interruption for the following local anaesthetic products:
| Product | ARTG | Current Status |
|---|---|---|
| Marcain 0.125% Epidural Infusion 200ml (sterile theatre pack) | 48374 | September 2021 |
| Marcain 0.25% 5 x 100mL (sterile theatre pack) | 11953 | October 2021 |
| Naropin 0.2% 5 x 200mL (sterile theatre pack) | 52395 | September 2021 |
| Naropin 0.2% with Fentanyl 200mcg/100mL (sterile theatre pack) | 72874 | October 2021 |
| Naropin 0.2% with Fentanyl 400mcg/100mL (sterile theatre pack) | 72876 | October 2021 |
| Naropin 0.2% with Fentanyl 800mcg/200mL (sterile theatre pack) | 72875 | December 2021 |
| Naropin 0.2% with Fentanyl 400mcg/200mL (sterile theatre pack) | 72873 | September 2021 |
All other local anaesthetic products marketed by Aspen are available as normal. HPS Pharmacies is pleased to advise that ropivacaine with fentanyl products are currently available from Baxter.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Aspen Pharmacare Australia on 1300 659 646.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates